243 related articles for article (PubMed ID: 34102997)
1. Lacosamide-induced sinus node dysfunction followed by severe agranulocytosis.
Shibata M; Hoshino R; Shimizu C; Sato M; Furuta N; Ikeda Y
BMC Neurol; 2021 Jun; 21(1):217. PubMed ID: 34102997
[TBL] [Abstract][Full Text] [Related]
2. Sinus node dysfunction: an adverse effect of lacosamide.
Chinnasami S; Rathore C; Duncan JS
Epilepsia; 2013 Jun; 54(6):e90-3. PubMed ID: 23360388
[TBL] [Abstract][Full Text] [Related]
3. Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
Baulac M; Byrnes W; Williams P; Borghs S; Webster E; De Backer M; Dedeken P
Acta Neurol Scand; 2017 Apr; 135(4):434-441. PubMed ID: 27714769
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
6. Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures.
Degiorgio CM
Epilepsy Behav; 2010 Jul; 18(3):322-4. PubMed ID: 20570216
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
[TBL] [Abstract][Full Text] [Related]
8. [Lacosamide associated with high-degree block in a patient with trigeminal neuralgia].
Marin-Gracia M; Cantero-Lozano D; Garces-Anton E; Lopez-Bravo A; Garrido-Fernandez A; Navarro-Perez MP; Santos-Lasaosa S; Garces-Redondo M
Rev Neurol; 2018 Mar; 66(6):189-192. PubMed ID: 29537058
[TBL] [Abstract][Full Text] [Related]
9. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.
Muñoz-Lopetegi A; López-González FJ; Rodríguez-Osorio X; Pato Pato A; Bellas Lamas P; Abella-Corral J; Castro Vilanova MD; Garea MJ; Gil López JA; Ruiz-Martínez J; Poza JJ
Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341
[TBL] [Abstract][Full Text] [Related]
10. Forced normalization of Lennox-Gastaut syndrome using lacosamide: A case report.
Ono-Takiguchi Y; Muramatsu K; Koshu K; Yamagata T
Brain Dev; 2021 Oct; 43(9):963-966. PubMed ID: 34049745
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience combined with therapeutic drug monitoring of lacosamide.
Svendsen T; Brodtkorb E; Baftiu A; Lossius MI; Nakken KO; Johannessen SI; Johannessen Landmark C
Acta Neurol Scand; 2020 Apr; 141(4):279-286. PubMed ID: 31853958
[TBL] [Abstract][Full Text] [Related]
12. Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy.
Izzi F; Placidi F; Liguori C; Posca I; Lauretti B; Diomedi M; Pisani A; Mercuri NB; Rocchi C
J Neurol Sci; 2020 Nov; 418():117095. PubMed ID: 32841918
[TBL] [Abstract][Full Text] [Related]
13. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients.
Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M
Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208
[TBL] [Abstract][Full Text] [Related]
14. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
15. Outcomes following exposure to lacosamide monotherapy during pregnancy and breastfeeding - a prospective case series.
Bosak M; Dziedzic R; Matwiej K; Słowik A
Neurol Neurochir Pol; 2024; 58(2):203-206. PubMed ID: 38305480
[TBL] [Abstract][Full Text] [Related]
16. Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy.
Nizam A; Mylavarapu K; Thomas D; Briskin K; Wu B; Saluja D; Wong S
Epilepsia; 2011 Oct; 52(10):e153-5. PubMed ID: 21801173
[TBL] [Abstract][Full Text] [Related]
17. Cardioembolic acute cerebral micro-infarcts in the context of atrial fibrillation after low-dose intravenous infusion of lacosamide.
Corbellini ÁB; Torre PP; Hristova VN; Sanz BZ; García ACC; Jorge FR; García JLC; Díaz PP; Catevilla FJB
Epileptic Disord; 2020 Feb; 22(1):83-89. PubMed ID: 32043469
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
Stephen LJ; Kelly K; Parker P; Brodie MJ
Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
[TBL] [Abstract][Full Text] [Related]
19. A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy.
Brigo F; Trinka E; Bragazzi NL; Nardone R; Milan A; Grillo E
Epilepsy Res; 2016 Nov; 127():12-18. PubMed ID: 27543806
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of treatment with lacosamide in children: Postmarketing experience from the Middle East.
Hmaimess G; Sabbagh S; Dirani M; Hotait M; Beydoun AA; Nasreddine W
Seizure; 2020 Jul; 79():75-79. PubMed ID: 32422546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
